Today some pathological conditions and gene defects such as reduced expression of BMPR2 or autosomal dominant mutations in the BMPR2 gene in hereditary PAH are known to favor disease development [19]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.